AzTrials
AzTrials

PainASDASNCT02741726

Analgesia by Single or Dual Acupoints Stimulation After Radical Mastectomy

A study testing acupoint stimulation and no stimulation in people with Pain, run by Zhihong LU at 6 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the effects of dual acupoints and single acupoint transcutaneous electrical acupoint stimulation (TEAS) pretreatment on incidence of Post-Mastectomy Pain Syndrome(PMPS) in patients undergoing operation of breast cancer. Read more about this study

Who is it for?
Ages 18 to 65 years, women only
Conditions the study is for
Pain
What is being tested?
acupoint stimulation and no stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
593 participants
Where
6 sitesChina
Study dates
25 May 2016to 23 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Scheduled for operation of breast cancer;
  • ASA(American Society of Anesthesiologists)I-II;
  • Aged between 18 and 65;
  • Informed consented。

Who cannot join

  • Suffered from the contraindication of TEAS including the local skin breakage, infection or planted with the electrophysiology device;
  • Unable to communicate and coordinate with the researcher, such as suffering from language comprehension deficits or mental diseases;
  • Certain/suspicious addiction with alcohol, analgesics or other drugs;
  • Unstable Angina or myocardial infarction occurred in 3 months; NYHA(New York Heart Association) is 3 or higher;
  • Blood pressure ≥ 180/110 mm Hg while preoperative visiting;
  • Suffered from diabetic complications including diabetic ketoacidosis, hyperosmolar coma, infection, macroangiopathy, diabetic nephropathy, retinopathy, cardiomyopathy, neuropathy and diabetic foot;
  • Severe dysfunction of liver or kidney meaning one of ALT(Alanine Transaminase), AST(Aspartate Transaminase), ALP(alkaline phosphatase) or TBIL(total bilirubin) is 2 times higher that normal or creatinine clearance < 30 ml/min or serum creatinine > 177umol/L;
  • Participate in the other clinical trial 3 month before the enrollment.

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

China6 sites
  • First Afiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality

  • Tangdu Hospital, Fourth Military Medical University

    Xi'an, Shaanxi, 710005

  • First Afiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, 710022

  • Xijing Hospital, Fourth Military Medical University

    Xi'an, Shaanxi, 710032

  • People's hospital of Zhengzhou University

    Zhengzhou, Henan, 450003

  • First Afiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450052

Other trials in China

About this study

Official title: Effect of Combined-acupoint or Single-acupoint Stimulation Before Surgery on Post Mastectomy Pain: a Multicentre Randomised Controlled Trial

The purpose of this study is to compare the effects of dual acupoints and single acupoint transcutaneous electrical acupoint stimulation (TEAS) pretreatment on incidence of Post-Mastectomy Pain Syndrome(PMPS) in patients undergoing operation of breast cancer.

Read the detailed description

Patients were randomly assigned to three groups, receiving 30min TEAS before anesthesia respectively. The acupoints of dual point group are bilateral Neiguan points(PC6) combined with Danzhong point(RN17), single point group is bilateral Neiguan points(PC6), and the false stimulation group only attach electrodes without electric current. The frequency of TEAS is set to 2/15 Hz. Intraoperative anesthetic dosage of propofol and remifentanil was recorded. Three and six months after surgery, follow-up about chronic pain was made by telephone or face-to-face using the follow-up questionnaire. The adverse events were recorded.

Conditions
Pain
Being tested
acupoint stimulation, no stimulation
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • acupoint stimulationDevice

    Also called transcutaneous electrical acupoint stimulation

    Electric stimulation was given through electrode attached to acupoints

  • no stimulationDevice

    patients were only attached electrodes without electric current

Study groups in NCT02741726
Study groupRoleWhat they receive
dual acupoint stimulationExperimentalThe acupoints of dual point group are bilateral Neiguan points(PC6) combined with Danzhong point(RN17), electric stimulation was given through electrode attached to the acupoints.
Receives: Device: acupoint stimulation
single acupoint stimulationExperimentalThe acupoints of single point group is bilateral Neiguan points(PC6), Electric stimulation was given through electrode attached to the acupoints.
Receives: Device: acupoint stimulation
no stimulationPlacebo comparatorfalse stimulation group only attach electrodes without electric current.
Receives: Device: no stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of chronic pain six months after surgery

    Measured: six months after surgery

Secondary outcomes (11)
  1. Incidence of chronic pain three months after surgery

    Measured: three months after surgery

  2. Remifentanil consumption during the surgery

    Measured: from start of surgery to end of surgery, at an average of 2.5 hours

  3. the time to the first verbal response

    Measured: end of the anesthetics infusion to patient's first response to verbal command,on an average of 30 minutes

  4. the time to extubation

    Measured: end of the anesthetics infusion to extubation,on an average of 30 minutes

  5. postoperative nausea and vomiting within 24 h after surgery

    Measured: end of surgery to 24 hours after surgery,on an average of 24 hours

  6. respiratory depression within 24 hours after surgery

    Measured: end of surgery to 24 hours after surgery,on an average of 24 hours

  7. patients' s satisfaction scores on analgesia within 24 hours after surgery

    Measured: end of surgery to 24 hours after surgery,on an average of 24 hours

  8. Visual Analogue Scale scores within 24 hours after surgery

    Measured: end of surgery to 24 hours after surgery,on an average of 24 hours

  9. demand of rescue analgesics within 24 hours after surgery

    Measured: end of surgery to 24 hours after surgery,on an average of 24 hours

  10. pain score at 3m after surgery

    Measured: three months after surgery

  11. pain score at 6m after surgery

    Measured: six months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2016 (estimated)
  2. Study start25 May 2016
  3. Primary completion23 Oct 2017
  4. Study completion23 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
593 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02741726
Sponsor's protocol ID
XJH-A-2016-04-12
Acronym
ASDAS
Status last verified
Oct 2019
First submitted
13 Apr 2016
Last updated
16 Oct 2019
Results posted
No
Individual data sharing
Yes: IPD including those about primary endpoint and secondary endpoints would be available to other researchers.

Publications

  • Lu Z, Wang Q, Sun X, Zhang W, Min S, Zhang J, Zhao W, Jiang J, Wang Y, Zhu Y, Zheng L, Wang Y, Guo Y, Zhang L, Wang L, Lei C, Liu T, Yang X, Zhang J, Li C, Zhang N, Dong H, Xiong L. Transcutaneous electrical acupoint stimulation before surgery reduces chronic pain after mastectomy: A randomized clinical trial. J Clin Anesth. 2021 Nov;74:110453. doi: 10.1016/j.jclinane.2021.110453. Epub 2021 Jul 13.

    PubMed 34271271

Questions about this trial

What is this clinical trial studying?

A study testing acupoint stimulation and no stimulation in people with Pain, run by Zhihong LU at 6 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of chronic pain six months after surgery (time frame: six months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02741726, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in